Torthaí cuardaigh - Raffaella Marcheselli
- 1 - 5 toradh as 5 á dtaispeáint
-
1
Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysis de réir Monica Pirani, Raffaella Marcheselli, Luigi Marcheselli, Alessia Bari, Massimo Federico, Stefano Sacchi
Foilsithe / Cruthaithe 2011Revisão -
2
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population‐based analysis de réir Samantha Pozzi, Luigi Marcheselli, Alessia Bari, Eliana Valentina Liardo, Raffaella Marcheselli, Stefano Luminari, Micol Quaresima, Claudia Cirilli, Paola Ferri, Massimo Federico, Stefano Sacchi
Foilsithe / Cruthaithe 2013Artigo -
3
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story de réir Alessia Bari, Luigi Marcheselli, Stefano Sacchi, Raffaella Marcheselli, Samantha Pozzi, Paola Ferri, Enrico Balleari, Pellegrino Musto, Santo Neri, Maria Antonietta Aloe Spiriti, Maria Christina Cox
Foilsithe / Cruthaithe 2009Artigo -
4
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study de réir Stefano Sacchi, Luigi Marcheselli, Alessia Bari, Raffaella Marcheselli, Samantha Pozzi, Stefano Luminari, Marco Lombardo, Gabriele Buda, Antonio Lazzaro, P. G. Gobbi, Caterina Stelitano, Fortunato Morabito, Giovanni Quarta, Maura Brugiatelli
Foilsithe / Cruthaithe 2008Artigo -
5
Neutrophil‐lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990... de réir Raffaella Marcheselli, Alessia Bari, Tamar Tadmor, Luigi Marcheselli, Maria Christina Cox, Samantha Pozzi, Angela Ferrari, Luca Baldini, Paolo G. Gobbi, Ariel Aviv, Giuseppe Pugliese, Massimo Federico, Aaron Polliack, Stefano Sacchi
Foilsithe / Cruthaithe 2016Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Internal medicine
Medicine
Lymphoma
Oncology
Cancer
Environmental health
Population
Confidence interval
Cancer registry
Clinical trial
Cohort
Cumulative incidence
Diffuse large B-cell lymphoma
Gastroenterology
Hazard ratio
Hodgkin lymphoma
Incidence (geometry)
Lymphocyte
Malignancy
Melphalan
Meta-analysis
Multiple myeloma
Multivariate analysis
Neutrophil to lymphocyte ratio
Nodular sclerosis
Optics
Overall survival
Physics
Proportional hazards model
Publication bias